Jump to content

Tyloxapol: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
add cat
Arcadian (talk | contribs)
{{Cough and cold preparations}} and infobox
Line 1: Line 1:
{{drugbox
| IUPAC_name =
| image =
| CAS_number =
| ATC_prefix = R05
| ATC_suffix = CA01
| PubChem =
| DrugBank =
| chemical_formula =
| molecular_weight =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
}}
'''Tyloxapol''' is a nonionic liquid [[polymer]] of the alkyl aryl polyether alcohol type; used as a [[surfactant]] to aid [[liquefaction]] and removal of mucopurulent (containing [[mucus]] and [[pus]]) bronchopulmonary secretions, administered by inhalation through a [[nebulizer]] or with a stream of oxygen.
'''Tyloxapol''' is a nonionic liquid [[polymer]] of the alkyl aryl polyether alcohol type; used as a [[surfactant]] to aid [[liquefaction]] and removal of mucopurulent (containing [[mucus]] and [[pus]]) bronchopulmonary secretions, administered by inhalation through a [[nebulizer]] or with a stream of oxygen.
Tyloxapol, when injected IP, also blocks plasma lipolytic activity, and thus the breakdown of [[triglyceride]]-rich [[lipoproteins]].
Tyloxapol, when injected IP, also blocks plasma lipolytic activity, and thus the breakdown of [[triglyceride]]-rich [[lipoproteins]].
{{pharma-stub}}
{{pharma-stub}}
{{Cough and cold preparations}}

[[pl:Tyloksapol]]
[[pl:Tyloksapol]]



Revision as of 00:56, 17 July 2007

Tyloxapol
Clinical data
ATC code
Identifiers
CompTox Dashboard (EPA)
ECHA InfoCard100.209.660 Edit this at Wikidata

Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type; used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. Tyloxapol, when injected IP, also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.